A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects

Clinical trial NCT04680429 · COMPLETED

Trial details

NCT number: NCT04680429
Sponsor: Rhizen Pharmaceuticals SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-12-29
Primary completion: 2021-07-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.